We looked to RPS6 for at least two reasons: (1) it is known that an abnormal protein synthesis rate occurs in many cancer types [23,24]; (2) it has been demonstrated that the SMN controls translation machinery at multiple levels [16,17,19,25]. This evidence concerns the gene SMN1 and cancer.